Kovach Eye Institute first in Illinois to offer patients new EVO/EVO+ Visian® Implantable Collamer® Lens

In March 2022, the U.S. Food and Drug Administration (FDA) granted approval of the EVO/EVO+ Visian Implantable Collamer Lens (EVO) for the correction of myopia and myopia with astigmatism. Myopia is also known as nearsightedness or the need for distance vision correction.

Related Keywords

Illinois ,United States ,South Barrington ,Elmhurst ,Lincolnwood ,Naperville ,Chicago ,Kevin Kovach ,Scottd Barnes ,George Ludwig ,Drug Administration ,Kovach Eye Institute ,Visian Implantable Collamer Lens ,Eye Institute ,Chief Medical Officer ,Managing Director ,Kovach Eye ,Visian Implantable Collamer Lenses ,News ,Tasca ,Wood Dale ,Ubmitted Content ,